PETER A. CLAUSEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Nuo Therapeutics, Inc.

Filing Date Source Excerpt
2014-05-02 Peter A. Clausen - Chief Science Officer of the Company. Includes 263,317 shares Mr. Clausen may acquire upon the exercise of stock options approved by the Board and issued under the Company’s 2002 Long-Term Incentive Plan and warrants.
2017-04-28 Peter A. Clausen - Chief Scientific Officer of the Company. Includes stock options granted under the Omnibus Plan.
2018-08-28 Peter A. Clausen - Chief Scientific Officer of the Company.

Data sourced from SEC filings. Last updated: 2026-02-03